Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Silence Therapeutics (SLNCF) Return on Invested Capital (2024 - 2025)

Historic Return on Invested Capital for Silence Therapeutics (SLNCF) over the last 2 years, with Q3 2025 value amounting to 0.99%.

  • Silence Therapeutics' Return on Invested Capital changed N/A to 0.99% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.99%, marking a year-over-year change of. This contributed to the annual value of 0.83% for FY2024, which is 17500.0% up from last year.
  • As of Q3 2025, Silence Therapeutics' Return on Invested Capital stood at 0.99%.
  • Over the past 5 years, Silence Therapeutics' Return on Invested Capital peaked at 0.49% during Q4 2024, and registered a low of 0.99% during Q3 2025.